Aydoğan, T., Erdoğan, G., Ünlü, C., & Ergin, A. (2016, December). Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia. Türk Oftalmoloji Dergisi.
Chicago Style (17th ed.) CitationAydoğan, Tuğba, Gürkan Erdoğan, Cihan Ünlü, and Ahmet Ergin. "Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia." Türk Oftalmoloji Dergisi Dec. 2016.
MLA (9th ed.) CitationAydoğan, Tuğba, et al. "Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia." Türk Oftalmoloji Dergisi, Dec. 2016.
Warning: These citations may not always be 100% accurate.
